Skip to main content
Clinical Trials/EUCTR2009-012763-34-AT
EUCTR2009-012763-34-AT
Active, not recruiting
Phase 1

Reversal of neuromuscular blockage in Patients with End Stage Hepatic Failure (listed for Liver Transplantation)

Medizinische Universität Wien, Univ. Klinik für Anästhesie, Allg. Intensivmedizin u Schmerztherapie0 sites22 target enrollmentAugust 11, 2009

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Medizinische Universität Wien, Univ. Klinik für Anästhesie, Allg. Intensivmedizin u Schmerztherapie
Enrollment
22
Status
Active, not recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 11, 2009
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Medizinische Universität Wien, Univ. Klinik für Anästhesie, Allg. Intensivmedizin u Schmerztherapie

Eligibility Criteria

Inclusion Criteria

  • Endstage liver failure and listing for liver transplantations as pointed out by the department of transplantation surgery
  • Age \>18 years
  • Willingness to participate attested in written consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • Known allergic reaction to Sugammadex

Outcomes

Primary Outcomes

Not specified

Similar Trials